Literature DB >> 2606936

Nicotine and estrogen metabolism--possible implications of smoking for growth and outcome of treatment of hormone-dependent cancer? Discussion of experimental results.

W J Zeller1, M R Berger.   

Abstract

The combination treatment of hormone-dependent autochthonous mammary carcinomas in the rat with nicotine plus HECNU, a water-soluble nitrosourea, resulted in a potentiation of antitumor action. Nicotine and its metabolite cotinine are strong inhibitors of the aromatase. With regard to investigations in smoking women, suggesting a decreased endogenous estrogen production, our results indicate that smoking might influence growth and treatment results of hormone-dependent human cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2606936     DOI: 10.1007/bf00391366

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  21 in total

1.  The influence of cigarette smoking and sex on theophylline disposition.

Authors:  J R Powell; J F Thiercelin; S Vozeh; L Sansom; S Riegelman
Journal:  Am Rev Respir Dis       Date:  1977-07

Review 2.  Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.

Authors:  N L Benowitz
Journal:  N Engl J Med       Date:  1988-11-17       Impact factor: 91.245

3.  Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide.

Authors:  P E Graves; H A Salhanick
Journal:  Endocrinology       Date:  1979-07       Impact factor: 4.736

4.  Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.

Authors:  J Jensen; C Christiansen; P Rødbro
Journal:  N Engl J Med       Date:  1985-10-17       Impact factor: 91.245

5.  Cigarette smoking, relative weight, and menopause.

Authors:  W Willett; M J Stampfer; C Bain; R Lipnick; F E Speizer; B Rosner; D Cramer; C H Hennekens
Journal:  Am J Epidemiol       Date:  1983-06       Impact factor: 4.897

6.  Microsomal metabolism of nitrosoureas.

Authors:  D L Hill; M C Kirk; R F Struck
Journal:  Cancer Res       Date:  1975-02       Impact factor: 12.701

7.  Basic studies on aminoglutethimide.

Authors:  H A Salhanick
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

8.  Effects of nicotine on epithelial nephron cells in culture.

Authors:  M Horster; H Brechtelsbauer; P Wilson; M Schmolke
Journal:  Klin Wochenschr       Date:  1984

9.  The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.

Authors:  V A Levin; J Stearns; A Byrd; A Finn; R J Weinkam
Journal:  J Pharmacol Exp Ther       Date:  1979-01       Impact factor: 4.030

10.  Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women.

Authors:  A R Williams; N S Weiss; C L Ure; J Ballard; J R Daling
Journal:  Obstet Gynecol       Date:  1982-12       Impact factor: 7.661

View more
  3 in total

1.  Fruit and vegetable intakes are associated with lower risk of breast fibroadenomas in Chinese women.

Authors:  Zakia Coriaty Nelson; Roberta M Ray; Chunyuan Wu; Helge Stalsberg; Peggy Porter; Johanna W Lampe; Jackilen Shannon; Neilann Horner; Wenjin Li; Wenwan Wang; Yongwei Hu; Daoli Gao; David B Thomas
Journal:  J Nutr       Date:  2010-05-19       Impact factor: 4.798

2.  Joint effects of smoking and gene variants involved in sex steroid metabolism on hot flashes in late reproductive-age women.

Authors:  Samantha F Butts; Ellen W Freeman; Mary D Sammel; Kaila Queen; Hui Lin; Timothy R Rebbeck
Journal:  J Clin Endocrinol Metab       Date:  2012-03-30       Impact factor: 5.958

Review 3.  Nicotine: Carcinogenicity and Effects on Response to Cancer Treatment - A Review.

Authors:  Tore Sanner; Tom K Grimsrud
Journal:  Front Oncol       Date:  2015-08-31       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.